QUANTUM GENOMICS EO -40
Quantum Genomics Société Anonyme is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of drugs to treat cardiovascular diseases. Quantum Genomics Société Anonyme was incorporated in 2005 and is headquartered in Paris, France.
QUANTUM GENOMICS EO -40 (2QG) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, QUANTUM GENOMICS EO -40 (2QG) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
QUANTUM GENOMICS EO -40 - Net Assets Trend (None–None)
This chart illustrates how QUANTUM GENOMICS EO -40's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for QUANTUM GENOMICS EO -40 (None–None)
The table below shows the annual net assets of QUANTUM GENOMICS EO -40 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to QUANTUM GENOMICS EO -40's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
QUANTUM GENOMICS EO -40 Competitors by Market Cap
The table below lists competitors of QUANTUM GENOMICS EO -40 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
UMS Holdings Bhd
KLSE:7137
|
$4.17 Million |
|
Israel Land Development Company Co Ltd
TA:ILDC
|
$4.17 Million |
|
Dom Maklerski IDM SA
WAR:IDM
|
$4.17 Million |
|
Digicontent Limited
NSE:DGCONTENT
|
$4.17 Million |
|
TPC Plus Bhd
KLSE:7176
|
$4.17 Million |
|
INTUITIVE SURGICAL - Dusseldorf Stock Exchang
DU:IUI1
|
$4.17 Million |
|
T.C.J. Asia Public Company Limited
BK:TCJ
|
$4.17 Million |
|
Bank Permata Tbk
JK:BNLI
|
$4.16 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in QUANTUM GENOMICS EO -40's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares QUANTUM GENOMICS EO -40's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently QUANTUM GENOMICS EO -40 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares QUANTUM GENOMICS EO -40's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $1,345,847,517
- Average return on equity (ROE) among peers: -601.64%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| QUANTUM GENOMICS EO -40 (2QG) | €- | N/A | N/A | $4.17 Million |
| 09R (09R) | $5.86 Million | -145.33% | 0.68x | $12.96 Million |
| IDORSIA AG (19T) | $104.20 Million | -608.99% | 13.23x | $582.75 Million |
| 1S90 (1S90) | $10.78 Million | -2319.92% | 31.35x | $54.21 Million |
| Strategic Partners A/S (1TB0) | $14.24 Million | -182.90% | 0.36x | $1.28 Million |
| 25K0 (25K0) | $-79.67 Million | 0.00% | 0.00x | $102.39 Million |
| 2BO (2BO) | $508.00K | -2193.11% | 12.24x | $9.80 Million |
| Intervacc AB (publ) (2E9) | $308.25 Million | -9.53% | 0.07x | $3.46 Million |
| 2F5 (2F5) | $-4.57 Million | 0.00% | 0.00x | $2.14 Million |
| 2H0 (2H0) | $3.03 Million | -558.03% | 2.82x | $9.20 Million |
| GNI Group Ltd (3G6) | $13.10 Billion | 1.39% | 0.57x | $772.60 Million |